Skip to main content

Table 10 ANOVA analysis for trospium chloride ER tablets DOE batches

From: Development, optimization and pharmacokinetic evaluation of biphasic extended-release osmotic drug delivery system of trospium chloride for promising application in treatment of overactive bladder

Response

Source

Sum of squares

df

Mean square

F value

p value

Remarks

Percent drug release at 2 h (acid stage)

Model

2027.00

7

289.57

62.76

 < 0.0001

significant

Residual

50.75

11

4.61

   

Cor Total

2212.95

19

    

Percent drug release at 5 h (Buffer stage)

Model

3980.94

7

568.71

79.95

 < 0.0001

significant

Residual

78.25

11

7.11

   

Cor Total

4267.20

19

    

Percent drug release at 11 h (Buffer stage)

Model

2317.00

8

289.63

66.20

 < 0.0001

significant

Residual

43.75

10

4.37

   

Cor Total

2405.75

19

    

Percent drug release at 20 h (Buffer stage)

Model

137.06

9

15.23

25.50

 < 0.0001

significant

Residual

5.37

9

0.5972

   

Cor Total

142.55

19

    
  1. df degrees of freedom, Cor Total Corrected total sum of squares; α: 0.05